Compliance shifts from single shipments to patterns over time. Consistency in identity, documentation, and rationale reveals structure that makes decisions traceable.
- The Atlantic Divide: Forcing FDA Demographics Onto European Supply Chains
- Expanding Clinical Trials In Africa Without Disruption
- Bridging Clinical Operations And Supply Chain: Aligning Execution In High-Stakes Trials
- At The Point Of Review: How Clinical Shipments Are Evaluated In Practice
- The cGMP Reality Of Clinical Supply For Advanced Therapies
- How Exit Strategy Should Shape Clinical Trial Supply Planning
- This Assumption Will Break Your Clinical Trial
- When Clinical Supply Fails, Small Biotech Trials Stall
ON-DEMAND WEBINARS
Succeed in combination product development by understanding the risk factors that may arise and implementing mitigation strategies that will streamline the device development process.
Clinical supply innovators from across the industry share their experiences and lessons learned as they work to normalize the use of adherence measurement tools and smart medicine packages.
In the era of seamless development, reducing time to the clinic and getting rapid approval is key. An integrated approach can accelerate timelines, avoid communication pitfalls, and improve outcomes.
Early planning mitigates risk by avoiding stock outs and study delays, minimizing waste with optimized inventory, and forecasting demand to facilitate robust supply planning.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![GettyImages-1354932664 tech provider]( "Considerations When Selecting An Interactive Response Technology Provider")
Considerations When Selecting An Interactive Response Technology ProviderInteractive response technology (IRT) systems ensure clinical trial participants receive the correct treatment, facilitate enhanced logistics tracking, and empower users to obtain real-time data.
-
![Laptop clinical trials iStock-653839742]( "What Are Decentralized Clinical Trials (DCTs)?")
What Are Decentralized Clinical Trials (DCTs)?Discover how DCTs leverage “virtual” tools, such as telemedicine, sensory-based technologies, wearable medical devices, and direct delivery of study drugs and materials to patients’ homes.
-
![APPROVED Rubber Stamp iStock-1178959563]( "Driving Successful Obesity Drug Development With GLP-1 Agonists")
Driving Successful Obesity Drug Development With GLP-1 AgonistsGLP-1 agonists are revolutionizing obesity treatment. Signant Health's ePRO solutions support over 30 trials, providing critical patient data and driving successful approvals.
-
![GettyImages-1312767504 data health]( "Using IRT Data To Automate And Optimize Clinical Supply")
Using IRT Data To Automate And Optimize Clinical SupplyLearn how clinical teams can save between $150,000 and $1 million in annual drug and shipping costs through automated supply optimization.
-
![GettyImages-1181190018 supply chain pharma, bio]( "End-To-End Inventory Control Supports Biotech's Expanding Portfolio")
End-To-End Inventory Control Supports Biotech's Expanding PortfolioMany organizations struggle with siloed operations, but this modern GxP inventory solution solves these challenges by providing a centralized, cloud-based platform for end-to-end visibility.
-
![GettyImages- 1317948272 drug delivery]( "RTSM Manages Clinical IP Dispensation In Schizophrenia Study")
RTSM Manages Clinical IP Dispensation In Schizophrenia StudyChallenged by the dispensation of an investigational product (IP) across diverse patient subgroups, see what solution this pharma was able to utilize to ensure optimal distribution and minimize wastage.
-
![03 West]( "Sample Sizes For Performance Testing Of Combination Products, Packaging")
Sample Sizes For Performance Testing Of Combination Products, PackagingWhen developing combination products or evaluating primary packaging for drug products one must evaluate the performance of the devices and the packaging to ensure that they are fit-for-purpose.
-
![analytical-timelines-GettyImages-2247278213]( "Compressing Analytical Timelines Without Cutting Corners")
Compressing Analytical Timelines Without Cutting CornersEfficient analytical development speeds decisions and improves risk visibility. Using QbD, digital tools, and strong communication helps teams accelerate timelines while maintaining rigor.
-
![GettyImages-2170642314-year 2025]( "What Does 2025 Hold For Pharma?")
What Does 2025 Hold For Pharma?Look at what’s in store for pharma and life science in 2025. While we see many recurring themes, 2025 promises to be filled with unexpected — and possibly unprecedented — developments.
-
![GettyImages-1156884561-fill-finish]( "Key Considerations For Selecting Flexible Fillers")
Key Considerations For Selecting Flexible FillersFlexible fillers are beneficial to drug developers looking for lifecycle management of their drug products. Explore key considerations for selecting flexible fill/finish manufacturing technologies.
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.
